<DOC>
	<DOCNO>NCT00463619</DOCNO>
	<brief_summary>Follow-Up Study Retarded Release Phosphatidylcholine Ulcerative Colitis Objectives : The objective study evaluate follow patient treat retarded release phosphatidylcholine three control , randomized study . Main question investigate whether treatment phosphatidylcholine could spare patient intake steroid immunosuppressant without clinical deterioration . Study population : - Retarded release phosphatidylcholine chronic-active ulcerative colitis . - Retarded release phosphatidylcholine steroid dependent ulcerative colitis . - Dose find study retard release phosphatidylcholine Outcome parameter : Definition remission : 1 . SCCAI &lt; 2,5 2 . Likert scale : grade 1 2 3. subjective impression remission : yes/no 4. blood stool Definition relapse : 1. subjective impression : yes/no 2 . SCCAI â‰¥ 5 3. blood stool Definition low clinical activity : SCCAI &lt; 5 Primary endpoint : sparing effect steroid and/or immunosuppressant rPC chronic active UC . Secondary endpoint 1. maintenance continuous remission 2. improvement disease activity : a. clinical activity ( SCCAI ) b.life quality ( SIBDQ-D ) c.Likert Score 3. relapse rate : a. time first relapse b. clinical activity relapse c. number relapse relation length treatment</brief_summary>
	<brief_title>Follow-up Study With Retarded Release Phosphatidylcholine Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients previous study retard release phosphatidylcholine patient less 6 week followup end initial study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>